Technical Analysis for XRTX - XORTX Therapeutics Inc.

Grade Last Price % Change Price Change
F 1.43 0.01% 0.00
XRTX closed up 0.01 percent on Friday, November 1, 2024, on 0 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 12
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Doji - Bullish? Reversal 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.01%
Wide Bands Range Expansion 0.01%
Down 3 Days in a Row Weakness 0.01%
Oversold Stochastic Weakness 0.01%
1,2,3 Pullback Bullish Bullish Swing Setup -3.38%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 22 hours ago
60 Minute Opening Range Breakout 1 day ago
Rose Above Previous Day's High 1 day ago
Up 3% 1 day ago
Up 2% 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

XORTX Therapeutics Inc. is a pharmaceutical company with two clinically advanced products in development – XRx-008 for Autosomal Dominant Polycystic Kidney Disease (ADPKD), XRx-101 for Coronavirus / COVID-19 infection and XRx-225 is a pre-clinical stage program for Type 2 Diabetic Nephropathy (T2DN). XORTX is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients.
Classification

Sector: Technology
Industry: Data Storage
Keywords: Pharmaceutical Organ Systems Infection Kidney Disease Kidney Diabetic Nephropathy Autosomal Dominant Polycystic Kidney Disease

Is XRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.9214
52 Week Low 1.09
Average Volume 3,589,711
200-Day Moving Average 2.39
50-Day Moving Average 1.71
20-Day Moving Average 1.63
10-Day Moving Average 1.53
Average True Range 0.22
RSI (14) 42.20
ADX 29.12
+DI 19.13
-DI 18.04
Chandelier Exit (Long, 3 ATRs) 1.85
Chandelier Exit (Short, 3 ATRs) 1.96
Upper Bollinger Bands 2.00
Lower Bollinger Band 1.27
Percent B (%b) 0.22
BandWidth 45.03
MACD Line -0.06
MACD Signal Line -0.04
MACD Histogram -0.0273
Fundamentals Value
Market Cap 2.86 Million
Num Shares 2 Million
EPS -3.60
Price-to-Earnings (P/E) Ratio -0.40
Price-to-Sales 0.00
Price-to-Book 0.76
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.72
Resistance 3 (R3) 1.71 1.60 1.67
Resistance 2 (R2) 1.60 1.53 1.61 1.66
Resistance 1 (R1) 1.52 1.48 1.56 1.53 1.64
Pivot Point 1.41 1.41 1.43 1.41 1.41
Support 1 (S1) 1.32 1.33 1.37 1.33 1.22
Support 2 (S2) 1.21 1.29 1.22 1.20
Support 3 (S3) 1.13 1.21 1.19
Support 4 (S4) 1.14